Study aims to find safer radiation approach for rectal cancer surgery
NCT ID NCT07346248
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at 266 adults with advanced rectal cancer who had radiation therapy followed by surgery. It compares standard chemoradiotherapy or short-course radiotherapy with a newer approach called total neoadjuvant treatment (TNT). The goal is to see which method leads to fewer complications within 90 days after surgery, helping doctors choose the safest option.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors choose safer treatment plans for rectal cancer patients, reducing post-surgery complications.
- What could go wrong
- This is a retrospective study, meaning it looks back at past data, so it cannot prove cause and effect. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER INDICATED TO NEOADJUVANT THERAPY AND SURGERY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
IRCCS Humanitas Research Hospital
Rozzano, Milan, 20089, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can precision protons spare rectal cancer patients from harsh side effects?
- Could a single drug replace surgery for rectal cancer?
- Can adding chemo after radiation help older adults with rectal cancer avoid surgery?
- Can a common muscle relaxant make radiation deadlier for rectal cancer?
- Timing of chemo may boost rectal cancer remission
- Immunotherapy combo may boost rectal cancer treatment